|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- |||| gentamicin sulfate / Generic mfg.
Enrollment open: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 12, 2014
P1/2, N=86, Recruiting, Sponsor: Royer Biomedical, Inc.
Not yet recruiting --> Recruiting
- ||||||| Invanz (ertapenem) / Merck (MSD)
Trial completion: Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) (clinicaltrials.gov) - Jan 5, 2014
P3, N=565, Completed, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||| Trial completion: A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 5, 2014
P2, N=75, Completed, Sponsor: Skingenix, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| New P2 trial: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - Dec 23, 2013
P2, N=72, Not yet recruiting, Sponsor: MediWound Ltd
- | Trial completion: A Test of the Investigational SEM Scanner (clinicaltrials.gov) - Dec 22, 2013
P=N/A, N=50, Completed, Sponsor: Bruin Biometrics, LLC
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Neuromuscular Electrical Therapy in Venous Ulcers (clinicaltrials.gov) - Dec 20, 2013
P4, N=20, Completed, Sponsor: Faculdade Evangelica do Parana
Recruiting --> Completed Recruiting --> Completed
- ||||| Januvia (sitagliptin) / Merck (MSD)
New P2 trial: Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 17, 2013
P2, N=250, Recruiting, Sponsor: Georgetown University
- Trial completion: DIAB-MMP2: Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 16, 2013
P0, N=59, Completed, Sponsor: University Hospital, Grenoble
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Dec 9, 2013
P4, N=30, Completed, Sponsor: Organogenesis
Recruiting --> Completed Recruiting --> Completed
- |||| Trial completion, Head-to-Head: Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers (clinicaltrials.gov) - Dec 9, 2013
P4, N=201, Completed, Sponsor: Molnlycke Health Care AB
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 9, 2013
P=N/A, N=40, Completed, Sponsor: MiMedx Group, Inc.
Recruiting --> Completed Recruiting --> Completed
- || New P3 trial, Head-to-Head: Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers. (clinicaltrials.gov) - Dec 5, 2013
P3, N=92, Not yet recruiting, Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.
- ||||| Epicyn / Sonoma Pharma, Amneal
New P4 trial: Pressure Ulcer Healing With Microcyn (clinicaltrials.gov) - Dec 3, 2013
P4, N=80, Recruiting, Sponsor: University of Alabama at Birmingham
- ||| Trial initiation date: A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers (clinicaltrials.gov) - Dec 1, 2013
P4, N=385, Recruiting, Sponsor: Cytomedix
Recruiting --> Completed Initiation date: Apr 2013 --> Oct 2013
- ||| Trial initiation date: Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 1, 2013
P4, N=380, Recruiting, Sponsor: Cytomedix
Initiation date: Apr 2013 --> Oct 2013 Initiation date: Apr 2013 --> Oct 2013
- || New P3 trial: PUPS: Pressure Ulcer Prevention Study in SCI (clinicaltrials.gov) - Dec 1, 2013
P3, N=170, Active, not recruiting, Sponsor: University of Southern California
- |||| Enrollment open: A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers (clinicaltrials.gov) - Dec 1, 2013
P4, N=385, Recruiting, Sponsor: Cytomedix
Initiation date: Apr 2013 --> Oct 2013 Not yet recruiting --> Recruiting
- |||| Enrollment open: Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 1, 2013
P4, N=380, Recruiting, Sponsor: Cytomedix
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||| Epicyn / Sonoma Pharma, Amneal
Enrollment open: Pressure Ulcer Healing With Microcyn (clinicaltrials.gov) - Nov 26, 2013
P4, N=80, Recruiting, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride (clinicaltrials.gov) - Nov 24, 2013
P1/2, N=1100, Completed, Sponsor: Bayside Health
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- lidocaine topical / Generic mfg.
Trial completion: M2P2: Cutaneous Microcirculation and Diabetic Foot (clinicaltrials.gov) - Nov 20, 2013
P=N/A, N=80, Completed, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed Recruiting --> Completed
- || Enrollment closed: A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 14, 2013
P=N/A, N=350, Active, not recruiting, Sponsor: Integra LifeSciences Corporation
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: SANIBA: Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers (clinicaltrials.gov) - Nov 12, 2013
P3, N=33, Completed, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting N=64 --> 33
- Trial completion: SANIBA: Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers (clinicaltrials.gov) - Nov 12, 2013
P3, N=33, Completed, Sponsor: Assistance Publique - H
N=64 --> 33 Recruiting --> Completed
- ||||| nitric oxide (EDX110) / Edixomed
New P1/2 trial: ProNOx1: Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 11, 2013
P1/2, N=140, Recruiting, Sponsor: Edixomed Ltd
- | Enrollment open: AIRPEDIA: Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management (clinicaltrials.gov) - Nov 7, 2013
P2/3, N=64, Recruiting, Sponsor: University Hospital, Grenoble
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| New P2/3 trial: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro (clinicaltrials.gov) - Nov 4, 2013
P2/3, N=250, Not yet recruiting, Sponsor: Tissue Therapies Ltd.
- gevokizumab (S 78989) / Novartis
Enrollment closed: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum (clinicaltrials.gov) - Nov 3, 2013
P2, N=8, Active, not recruiting, Sponsor: XOMA (US) LLC
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||||||||| New P3 trial: Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 (clinicaltrials.gov) - Oct 24, 2013
P3, N=440, Not yet recruiting, Sponsor: Smith & Nephew, Inc.
- ||||| New P4 trial: DermACELL in Subjects With Chronic Wounds of the Lower Extremities (clinicaltrials.gov) - Oct 21, 2013
P4, N=200, Recruiting, Sponsor: LifeNet Health
- |||| Enrollment open: DermACELL in Subjects With Chronic Wounds of the Lower Extremities (clinicaltrials.gov) - Oct 21, 2013
P4, N=200, Recruiting, Sponsor: LifeNet Health
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | New P2 trial: Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia (clinicaltrials.gov) - Oct 17, 2013
P2, N=36, Recruiting, Sponsor: Molnlycke Health Care AB
- | New P4 trial: MxT Ag 05: TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended (clinicaltrials.gov) - Oct 15, 2013
P4, N=30, Recruiting, Sponsor: Molnlycke Health Care AB
- New P4 trial: ANGIOCATH: To Assess Analgesia Provided by Continuous Sciatic Nerve Block in Patients With Hypertensive Leg Ulcer (clinicaltrials.gov) - Oct 15, 2013
P4, N=30, Not yet recruiting, Sponsor: Nantes University Hospital
- New P2 trial: Treatment of the Hypertensive Leg Ulcers by PRF Application (clinicaltrials.gov) - Oct 6, 2013
P2, N=18, Not yet recruiting, Sponsor: University Hospital, Strasbourg, France
- Enrollment closed: MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers (clinicaltrials.gov) - Sep 26, 2013
P=N/A, N=40, Active, not recruiting, Sponsor: Cardiff and Vale University Health Board
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial termination: Oxandrolone to Heal Pressure Ulcers (clinicaltrials.gov) - Sep 22, 2013
P3, N=212, Terminated, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Completed --> Terminated; futility analysis showed low probability of detecting a significant difference
- Trial withdrawal: BIONs, for Improved Tissue Health and Pressure Sore Prevention (clinicaltrials.gov) - Sep 15, 2013
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Completed --> Terminated; futility analysis showed low probability of detecting a significant difference Terminated --> Withdrawn
- Trial completion: Low Friction Bed Sheet (clinicaltrials.gov) - Sep 12, 2013
P=N/A, N=20, Completed, Sponsor: Swiss Paraplegic Centre Nottwil
Terminated --> Withdrawn Not yet recruiting --> Completed
- Cubicin (daptomycin) / Merck (MSD)
Trial termination, HEOR, Gram positive: Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens (clinicaltrials.gov) - Sep 8, 2013
P4, N=6, Terminated, Sponsor: Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Not yet recruiting --> Completed Active, not recruiting --> Terminated; Lack of patient enrollment
- Cubicin (daptomycin) / Merck (MSD)
Enrollment change, HEOR, Gram positive: Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens (clinicaltrials.gov) - Sep 8, 2013
P4, N=6, Terminated, Sponsor: Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Active, not recruiting --> Terminated; Lack of patient enrollment N=80 --> 6
- Trial completion: CaPAS: Characterization of Sitting Postures in Healthy Subjects (clinicaltrials.gov) - Sep 8, 2013
P=N/A, N=30, Completed, Sponsor: University Hospital, Grenoble
N=80 --> 6 Recruiting --> Completed
- Trial termination: [124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection (clinicaltrials.gov) - Aug 19, 2013
P2, N=4, Terminated, Sponsor: BioMed Valley Discoveries, Inc
Recruiting --> Completed Recruiting --> Terminated; No correlation between FIAU uptake and bone biopsy results.
- Enrollment change: [124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection (clinicaltrials.gov) - Aug 19, 2013
P2, N=4, Terminated, Sponsor: BioMed Valley Discoveries, Inc
Recruiting --> Terminated; No correlation between FIAU uptake and bone biopsy results. N=25 --> 4
- Trial termination: Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds (clinicaltrials.gov) - Aug 5, 2013
P4, N=9, Terminated, Sponsor: Schülke & Mayr GmbH
N=25 --> 4 Recruiting --> Terminated; early termination due to poor recruitment
- Enrollment change: Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds (clinicaltrials.gov) - Aug 5, 2013
P4, N=9, Terminated, Sponsor: Schülke & Mayr GmbH
Recruiting --> Terminated; early termination due to poor recruitment N=70 --> 9
- | Enrollment change: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - Jul 16, 2013
P4, N=30, Recruiting, Sponsor: Hollister Incorporated
N=70 --> 9 N=40 --> 30
- Enrollment open: PRP-2012: Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers (clinicaltrials.gov) - Jul 14, 2013
P1/2, N=40, Recruiting, Sponsor: Basque Health Service
N=40 --> 30 Not yet recruiting --> Recruiting
- Trial withdrawal: Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients (clinicaltrials.gov) - Jul 14, 2013
P=N/A, N=0, Withdrawn, Sponsor: B. Braun Medical Inc.
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Enrollment change: Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients (clinicaltrials.gov) - Jul 14, 2013
P=N/A, N=0, Withdrawn, Sponsor: B. Braun Medical Inc.
Recruiting --> Withdrawn N=40 --> 0